Picture of Cyxone AB logo

CYXO — Cyxone AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cyxone's Four Patent Applications Pertaining To Its Drug Candidate Rabeximod Published

Dec 17 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE REPORTS PUBLICATION OF FOUR PATENT APPLICATIONS
PERTAINING TO ITS DRUG CANDIDATE RABEXIMOD
    * FOUR PATENT APPLICATIONS PERTAINING TO ITS DRUG CANDIDATE
RABEXIMOD HAVE BEEN PUBLISHED BY PERCENT AUTHORITY (WIPO)
    * IF APPROVED, THESE PATENTS HAVE POTENTIAL TO PROLONG
MARKET
EXCLUSIVITY OF RABEXIMOD UNTIL 2041.

Source text for Eikon:  ID:nWkr1m07mQ 
Further company coverage:  CYXO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Cyxone AB

See all news